Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.3031 per EA under NDC 16714080801. Its NADAC has been published 406 times since Nov 14, 2018.

FDA first approved this application on Sep 9, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714080801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040480

FDA Approved

9/9/2003

TE Code

AB

On Market Since

9/9/2003

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 406 times since Nov 14, 2018, and over the history we have for it it has declined 42.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3031 per EA
All-time high$0.5511 (Dec 12, 2018)
All-time low$0.2416 (Jul 17, 2024)
52-week high$0.3250
52-week low$0.2992
Median price$0.3305
Average price$0.3554
Largest weekly change-26.9% (Nov 20, 2024)
Weeks tracked406
Tracking sinceNov 14, 2018

Price History

1W

+1.3%

1M

+1.3%

3M

-0.8%

6M

-2.7%

1Y

-6.7%

3Y

-15.5%

5Y

-17.2%

All

-42.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by NorthStar Rx LLC, is $0.3031 per EA (NDC 16714080801), effective Aug 19, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 42.6%. It has been tracked across 406 weekly CMS publications since Nov 14, 2018.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Nov 14, 2018, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.5511 (Dec 12, 2018), with a median of $0.3305 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 16714080801) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.